Dr. Andrea Cercek, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Colorectal Cancer
Studies Rectal Cancer
15 reported clinical trials
32 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
Stage III
MSI-H positive
2Rectal Cancer
Stage III
MMR positive
MSI positive
Affiliated Hospitals
Clinical Trials Andrea Cercek, MD is currently running
Tucatinib + Trastuzumab
for Rectal Cancer
This trial is testing a new treatment for people with rectal cancer. It uses two drugs, trastuzumab and tucatinib, along with standard chemotherapy. These drugs aim to block proteins that help cancer grow, while chemotherapy kills the cancer cells.
Recruiting1 award Phase 2
Study
for Young Onset Colorectal Cancer
This study will collect biospecimens (including blood, tissue, and stool samples) and health information to create a database-a type of collection of information-for better understanding young onset colorectal cancer (YOCRC). The study will include both people with YOCRC and healthy people.
Recruiting1 award N/A5 criteria
More about Andrea Cercek, MD
Clinical Trial Related2 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Andrea Cercek, MD has experience with
- Bevacizumab
- Trastuzumab
- Tucatinib
- Floxuridine
- Oxaliplatin
- Irinotecan
Breakdown of trials Andrea Cercek, MD has run
Colorectal Cancer
Rectal Cancer
Colon Cancer
Liver Cancer
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrea Cercek, MD specialize in?
Andrea Cercek, MD focuses on Colorectal Cancer and Rectal Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are Stage III.
Is Andrea Cercek, MD currently recruiting for clinical trials?
Yes, Andrea Cercek, MD is currently recruiting for 9 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Andrea Cercek, MD has studied deeply?
Yes, Andrea Cercek, MD has studied treatments such as Bevacizumab, Trastuzumab, Tucatinib.
What is the best way to schedule an appointment with Andrea Cercek, MD?
Apply for one of the trials that Andrea Cercek, MD is conducting.
What is the office address of Andrea Cercek, MD?
The office of Andrea Cercek, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.